News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial
Aug 21, 2025, 14:07

NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial

UF Health Cancer Center shared on LinkedIn:

“Myosin Therapeutics Inc., a biotechnology company developing novel therapies for aggressive cancers led by UF Health Cancer Center member Courtney A. Miller, has been awarded a $4.5 million grant from the National Cancer Institute (NCI).

The funding will support a clinical trial testing a novel treatment for glioblastoma that was crafted by scientists at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology. The potential treatment renders the deadly brain cancer newly sensitive to both radiation and chemotherapy drugs, and blocks the cancer’s ability to invade other tissue, a new study showed.

Read more about this news.”

More posts featuring UF Health Cancer Center.

brain cancer cancer cancer treatment Courtney A. Miller glioblastoma Myosin Therapeutics Inc. National Cancer Institute NCI OncoDaily Oncology The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology UF Health Cancer Center
Special Coverage
Voices
Aug 21, 2025, 14:07
NCI Awards $4.5M to Myosin Therapeutics for Groundbreaking Glioblastoma Clinical Trial
Voices
Aug 21, 2025, 14:06
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute is Expanding its Clinical Research Team
Voices
Aug 21, 2025, 14:01
IU Simon Cancer Center Engages 1,800 Fairgoers at Indiana State Fair
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts